These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21720167)

  • 1. A syngeneic orthotopic murine model of pancreatic adenocarcinoma in the C57/BL6 mouse using the Panc02 and 6606PDA cell lines.
    Partecke LI; Sendler M; Kaeding A; Weiss FU; Mayerle J; Dummer A; Nguyen TD; Albers N; Speerforck S; Lerch MM; Heidecke CD; von Bernstorff W; Stier A
    Eur Surg Res; 2011; 47(2):98-107. PubMed ID: 21720167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of an orthotopic pancreatic cancer mouse model: cells suspended and injected in Matrigel.
    Jiang YJ; Lee CL; Wang Q; Zhou ZW; Yang F; Jin C; Fu DL
    World J Gastroenterol; 2014 Jul; 20(28):9476-85. PubMed ID: 25071342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two syngeneic orthotopic murine models of pancreatic adenocarcinoma.
    Nikfarjam M; Yeo D; He H; Baldwin G; Fifis T; Costa P; Tan B; Yang E; Wen Sw; Christophi C
    J Invest Surg; 2013 Dec; 26(6):352-9. PubMed ID: 23957638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy.
    Erstad DJ; Sojoodi M; Taylor MS; Ghoshal S; Razavi AA; Graham-O'Regan KA; Bardeesy N; Ferrone CR; Lanuti M; Caravan P; Tanabe KK; Fuchs BC
    Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29903803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncoupling protein 2 deficiency of non-cancerous tissues inhibits the progression of pancreatic cancer in mice.
    Revskij D; Runst J; Umstätter C; Ehlers L; Rohde S; Zechner D; Bastian M; Müller-Hilke B; Fuellen G; Henze L; Murua Escobar H; Junghanss C; Kowald A; Walter U; Köhling R; Wolkenhauer O; Jaster R
    Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):190-199. PubMed ID: 36549966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of novel carcinoma cell lines for the analysis of therapeutical strategies fighting pancreatic cancer.
    Zechner D; Bürtin F; Amme J; Lindner T; Radecke T; Hadlich S; Kühn JP; Vollmar B
    Cell Biosci; 2015; 5():51. PubMed ID: 26322225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAIL Promotes Tumor Growth in a Syngeneic Murine Orthotopic Pancreatic Cancer Model and Affects the Host Immune Response.
    Beyer K; Normann L; Sendler M; Käding A; Heidecke CD; Partecke LI; von Bernstorff W
    Pancreas; 2016 Mar; 45(3):401-8. PubMed ID: 26390425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases model.
    Partecke IL; Kaeding A; Sendler M; Albers N; Kühn JP; Speerforck S; Roese S; Seubert F; Diedrich S; Kuehn S; Weiss UF; Mayerle J; Lerch MM; Hadlich S; Hosten N; Heidecke CD; Puls R; von Bernstorff W
    BMC Cancer; 2011 Jan; 11():40. PubMed ID: 21276229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel, clinically relevant animal model of metastatic pancreatic adenocarcinoma biology and therapy.
    Wang B; Shi Q; Abbruzzese JL; Xiong Q; Le X; Xie K
    Int J Pancreatol; 2001; 29(1):37-46. PubMed ID: 11558631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of M2-macrophages by tumour cells and tumour growth promotion by M2-macrophages: a quid pro quo in pancreatic cancer.
    Partecke LI; Günther C; Hagemann S; Jacobi C; Merkel M; Sendler M; van Rooijen N; Käding A; Nguyen Trung D; Lorenz E; Diedrich S; Weiss FU; Heidecke CD; von Bernstorff W
    Pancreatology; 2013; 13(5):508-16. PubMed ID: 24075516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
    Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of 3.0 tesla magnetic resonance imaging for diagnosis in the orthotopic nude mouse model of pancreatic cancer.
    Wu L; Wang C; Yao X; Liu K; Xu Y; Zhang H; Fu C; Wang X; Li Y
    Exp Anim; 2014; 63(4):403-13. PubMed ID: 25048266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.
    Clary BM; Coveney EC; Philip R; Blazer DG; Morse M; Gilboa E; Lyerly HK
    Cancer Gene Ther; 1997; 4(2):97-104. PubMed ID: 9080118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic resistance to anticancer agents in the murine pancreatic adenocarcinoma PANC02.
    Priebe TS; Atkinson EN; Pan BF; Nelson JA
    Cancer Chemother Pharmacol; 1992; 29(6):485-9. PubMed ID: 1348974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination.
    Collignon A; Perles-Barbacaru AT; Robert S; Silvy F; Martinez E; Crenon I; Germain S; Garcia S; Viola A; Lombardo D; Mas E; Béraud E
    Oncotarget; 2015 Sep; 6(27):23462-79. PubMed ID: 26405163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model.
    Takenaga K; Akimoto M; Koshikawa N; Nagase H
    PLoS One; 2020; 15(4):e0232230. PubMed ID: 32340025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental orthotopic prostate tumor in nude mice: techniques for local cell inoculation and three-dimensional ultrasound monitoring.
    Saar M; Körbel C; Jung V; Suttmann H; Grobholz R; Stöckle M; Unteregger G; Menger MD; Kamradt J
    Urol Oncol; 2012; 30(3):330-8. PubMed ID: 20452251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor properties of the cGMP/protein kinase G inhibitor DT3 in pancreatic adenocarcinoma.
    Soltek S; Karakhanova S; Golovastova M; D'Haese JG; Serba S; Nachtigall I; Philippov PP; Werner J; Bazhin AV
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Nov; 388(11):1121-8. PubMed ID: 26105003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An orthotopic nude mouse model for evaluating pathophysiology and therapy of pancreatic cancer.
    Hotz HG; Reber HA; Hotz B; Yu T; Foitzik T; Buhr HJ; Cortina G; Hines OJ
    Pancreas; 2003 May; 26(4):e89-98. PubMed ID: 12717279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.